Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Animal Genetics|February 26, 2000
Nomenclature for factors of the dog major histocompatibility system (DLA), 1998: first report of the ISAG DLA Nomenclature CommitteeL J Kennedy, L Altet, J M Angles, et al.
Tissue Antigens|October 16, 1999
Nomenclature for factors of the dog major histocompatibility system (DLA), 1998. First report of the ISAG DLA Nomenclature Committee. International Society for Animals GeneticsL J Kennedy, L Altet, J M Angles, et al.
Diabetes|July 2, 1999
Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154N S Kenyon, L A Fernandez, R Lehmann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.
Bone Marrow Transplantation|August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen, M Boeckh, K Seidel, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Bone Marrow Transplantation|February 10, 2004
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphomaG L Phillips, B R Meisenberg, D E Reece, et al.
Blood|May 23, 2001
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsP A McSweeney, D Niederwieser, J A Shizuru, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunityE Schueddig, V Kochat, E Arslan, et al.
Bone Marrow Transplantation|August 25, 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantationG L Uy, L J Costa, P N Hari, et al.
Pageof 9